Company intelligence / Profile preview

Cilo Cybin

Ownership: Private
Development stage: Commercial

Overview

Cilo Cybin operates South Africa’s first fully vertically integrated medical cannabis business with both cultivation and manufacturing licenses. Their indoor facility holds GACP accreditation and their manufacturing site meets cGMP standards. They export medical-grade cannabis flower and offer contract manufacturing services. The company plans to expand into psychedelic drug R&D pending regulatory approval but has not yet launched clinical programs in this area

Therapeutic areas: PsychiatryNeurology
Modalities: Medical cannabis (plant-derived products)potential future psychedelic drugs (planned R&D)
Industry: Non-Drug Biotech

Partnerships

ALPS Global Holding—collaboration on clinical trial support and genomics/personalized medicine strategies

Beyond the preview

Go deeper on Cilo Cybin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cilo Cybin.

Explore the full profile